Cumberland Pharmaceutical... (CPIX)
NASDAQ: CPIX
· Real-Time Price · USD
3.29
-0.07 (-2.08%)
At close: Oct 14, 2025, 10:03 AM
Cumberland Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 37.87M | 39.55M | 42.01M | 35.99M |
Cost of Revenue | 6.59M | 6.07M | 9.12M | 8.81M |
Gross Profit | 31.28M | 33.49M | 32.89M | 27.17M |
Operating Income | -6.43M | -6.21M | -5.7M | -7.68M |
Interest Income | 334.44K | 286.85K | 98.41K | 26.08K |
Pretax Income | -6.47M | -6.28M | -5.58M | -5.56M |
Net Income | -6.48M | -6.28M | -5.65M | -5.6M |
Selling & General & Admin | 28.15M | 29.1M | 26.84M | 24.8M |
Research & Development | 4.82M | 5.83M | 6.69M | 5.68M |
Other Expenses | 4.75M | 8.1M | 5.07M | 4.37M |
Operating Expenses | 37.71M | 43.04M | 38.6M | 34.85M |
Interest Expense | 605.51K | 667.86K | 586K | 98.03K |
Selling & Marketing Expenses | 17.02M | 18.45M | 16.66M | 15.02M |
Cost & Expenses | 44.3M | 49.11M | 47.72M | 43.66M |
Income Tax Expense | -22.67K | 45.77K | 68.85K | 34.89K |
Shares Outstanding (Basic) | 14.06M | 14.3M | 14.56M | 14.9M |
Shares Outstanding (Diluted) | 14.06M | 14.3M | 14.56M | 14.9M |
EPS (Basic) | -0.46 | -0.44 | -0.39 | -0.38 |
EPS (Diluted) | -0.46 | -0.44 | -0.39 | -0.38 |
EBITDA | 182.42K | 153.32K | 332.92K | -857.83K |
EBIT | -5.86M | -5.62M | -5M | -5.46M |
Depreciation & Amortization | 6.04M | 5.77M | 5.33M | 4.61M |